Muğla Sıtkı Koçman University

mu.edu.tr

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

108

Active

14

Phase 3

0

Total enrollment

32,893

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Postoperative Pain4
  • Knee Arthroplasty3
  • Exercise3
  • Oxidative Stress3
  • Coronary Artery Bypass2
  • Geriatrics2
  • Cholesterol (Total and HDL)2
  • Cerebral Palsy, Spastic2

Frequently asked questions about Muğla Sıtkı Koçman University

How many clinical trials does Muğla Sıtkı Koçman University have on ClinicalTrials.gov?
Muğla Sıtkı Koçman University is listed as the lead sponsor on 108 clinical trials in ClinicalTrials.gov, 14 of which are currently active (recruiting, enrolling, or ongoing).
How many of Muğla Sıtkı Koçman University's trials are in Phase 3?
0 of Muğla Sıtkı Koçman University's trials are in Phase 3.
What therapeutic areas does Muğla Sıtkı Koçman University focus on?
Muğla Sıtkı Koçman University's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Knee Arthroplasty, Exercise, Oxidative Stress, Coronary Artery Bypass.